Geriatric conditions, medication use, and risk of adverse drug events in a predominantly male, older veteran population

Journal of the American Geriatrics Society

Volumn 59, Issue 4, 2011, Pages 615-621

  Steinman, Michael A ^a,b,g   Lund, Brian C ^c,d   Miao, Yinghui ^a,b   Boscardin, W John ^a,b,e   Kaboli, Peter J ^c,f  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Department of Biostatistics   (United States)

^f UNIVERSITY OF IOWA   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

drug therapy adverse effects; frail elderly; polypharmacy

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDIABETIC AGENT; BENZODIAZEPINE DERIVATIVE; DIGOXIN; LOOP DIURETIC AGENT; WARFARIN;

ADVERSE DRUG REACTION; AGED; ARTICLE; COGNITIVE DEFECT; COHORT ANALYSIS; CONSTIPATION; DEPRESSION; DRUG USE; FEMALE; FRAIL ELDERLY; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; GERIATRIC DISORDER; HUMAN; INCONTINENCE; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; STRUCTURED INTERVIEW; VETERAN; VISUAL IMPAIRMENT;

EID: 79954834271     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03331.x     Document Type: Article

References (39)

1. Carey EC, Covinsky KE, Lui LY, et al,. Prediction of mortality in community-living frail elderly people with long-term care needs. J Am Geriatr Soc 2008; 56: 68-75.
2. Tinetti ME, Kumar C., The patient who falls: "It's always a trade-off". JAMA 2010; 303: 258-266.
3. Mehta KM, Yaffe K, Langa KM, et al,. Additive effects of cognitive function and depressive symptoms on mortality in elderly community-living adults. J Gerontol A Biol Sci Med Sci 2003; 58A: M461-M467.
4. Holroyd-Leduc JM, Straus SE., Management of urinary incontinence in women: Scientific review. JAMA 2004; 291: 986-995.
5. Fried LP, Ferrucci L, Darer J, et al,. Untangling the concepts of disability, frailty, and comorbidity: Implications for improved targeting and care. J Gerontol A Biol Sci Med Sci 2004; 59A: 255-263.
6. Gupta V, Lipsitz LA., Orthostatic hypotension in the elderly: Diagnosis and treatment. Am J Med 2007; 120: 841-847.
7. von Renteln-Kruse W, Thiesemann N, Thiesemann R, et al,. Does frailty predispose to adverse drug reactions in older patients? Age Ageing 2000; 29: 461-462.
8. Forster AJ, Clark HD, Menard A, et al,. Adverse events among medical patients after discharge from hospital. Can Med Assoc J 2004; 170: 345-349. (Pubitemid 38223452)
9. Gray SL, Sager M, Lestico MR, et al,. Adverse drug events in hospitalized elderly. J Gerontol A Biol Sci Med Sci 1998; 53A: M59-M63. (Pubitemid 128763923)
10. Chrischilles E, Rubenstein L, Van Gilder R, et al,. Risk factors for adverse drug events in older adults with mobility limitations in the community setting. J Am Geriatr Soc 2007; 55: 29-34. (Pubitemid 46046225)
11. Gray SL, Mahoney JE, Blough DK., Adverse drug events in elderly patients receiving home health services following hospital discharge. Ann Pharmacother 1999; 33: 1147-1153.
12. Onder G, Gambassi G, Scales CJ, et al,. Adverse drug reactions and cognitive function among hospitalized older adults. Eur J Clin Pharmacol 2002; 58: 371-377. (Pubitemid 34983929)
13. Ganjavi H, Herrmann N, Rochon PA, et al,. Adverse drug events in cognitively impaired elderly patients. Dement Geriatr Cogn Disord 2007; 23: 395-400. (Pubitemid 46897176)
14. Onder G, Petrovic M, Tangiisuran B, et al,. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: The GerontoNet ADR risk score. Arch Intern Med 2010; 170: 1142-1148.
15. Chrischilles EA, Foley DJ, Wallace RB, et al,. Use of medications by persons 65 and over: Data from the established populations for epidemiologic studies of the elderly. J Gerontol 1992; 47: M137-M144.
16. Lund BC, Carnahan RM, Egge JA, et al,. Inappropriate prescribing predicts adverse drug events in older adults. Ann Pharmacother 2010; 44: 957-963.
17. Folli HL, Poole RL, Benitz WE., Medication error prevention by clinical pharmacists in two children's hospitals. Pediatrics 1987; 79: 718-722. (Pubitemid 17087137)
18. Bates DW, Spell N, Cullen DJ, et al,. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997; 277: 307-311. (Pubitemid 27045011)
19. Budnitz DS, Shehab N, Kegler SR, et al,. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007; 147: 755-765. (Pubitemid 351664440)
20. Chrischilles EA, VanGilder R, Wright K, et al,. Inappropriate medication use as a risk factor for self-reported adverse drug effects in older adults. J Am Geriatr Soc 2009; 57: 1000-1006.
21. Woolcott JC, Richardson KJ, Wiens MO, et al,. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009; 169: 1952-1960.
22. Field TS, Gurwitz JH, Harrold LR, et al,. Risk factors for adverse drug events among older adults in the ambulatory setting. J Am Geriatr Soc 2004; 52: 1349-1354. (Pubitemid 39038210)
23. Lee SJ, Moody-Ayers SY, Landefeld CS, et al,. The relationship between self-rated health and mortality in older black and white Americans. J Am Geriatr Soc 2007; 55: 1624-1629. (Pubitemid 47508494)
24. Yaffe K, Edwards ER, Covinsky KE, et al,. Depressive symptoms and risk of mortality in frail, community-living elderly persons. Am J Geriatr Psychiatry 2003; 11: 561-567. (Pubitemid 37093383)
25. Unutzer J., Clinical practice. Late-life depression. N Engl J Med 2007; 357: 2269-2276.
26. Rosenberg EA, Sperazza LC., The visually impaired patient. Am Fam Phys 2008; 77: 1431-1436.
27. Rockwood K, Mitnitski A., Frailty in relation to the accumulation of deficits. J Gerontol A Biol Sci Med Sci 2007; 62A: 722-727. (Pubitemid 350143602)
28. Hastings SN, Purser JL, Johnson KS, et al,. Frailty predicts some but not all adverse outcomes in older adults discharged from the emergency department. J Am Geriatr Soc 2008; 56: 1651-1657.
29. Corsonello A, Pedone C, Corica F, et al,. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 2005; 165: 790-795. (Pubitemid 40569433)
30. Klabunde CN, Warren JL, Legler JM., Assessing comorbidity using claims data: An overview. Med Care 2002; 40 (Suppl 8): IV-26-IV-35.
31. Saliba D, Elliott M, Rubenstein LZ, et al,. The Vulnerable Elders Survey: A tool for identifying vulnerable older people in the community. J Am Geriatr Soc 2001; 49: 1691-1699.
32. Blenkinsopp A, Wilkie P, Wang M, et al,. Patient reporting of suspected adverse drug reactions: A review of published literature and international experience. Br J Clin Pharmacol 2007; 63: 148-156.
33. Weingart SN, Gandhi TK, Seger AC, et al,. Patient-reported medication symptoms in primary care. Arch Intern Med 2005; 165: 234-240.
34. Mannesse CK, Derkx FH, de Ridder MA, et al,. Do older hospital patients recognize adverse drug reactions? Age Ageing 2000; 29: 79-81. (Pubitemid 30055069)
35. Sarkisian CA, Liu H, Ensrud KE, et al,. Correlates of attributing new disability to old age. Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc 2001; 49: 134-141. (Pubitemid 32207221)
36. Rochon PA, Gurwitz JH., Optimising drug treatment for elderly people: The prescribing cascade. BMJ 1997; 315: 1096-1099.
37. Forster AJ, Murff HJ, Peterson JF, et al,. Adverse drug events occurring following hospital discharge. J Gen Intern Med 2005; 20: 317-323. (Pubitemid 40617599)
38. Hanlon JT, Schmader KE, Koronkowski MJ, et al,. Adverse drug events in high risk older outpatients. J Am Geriatr Soc 1997; 45: 945-948. (Pubitemid 27330124)
39. Green JL, Hawley JN, Rask KJ., Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population? Am J Geriatr Pharmacother 2007; 5: 31-39. (Pubitemid 47099502)